TipRanks
Advertisement
Advertisement

CTNM Stock Latest News

Jones sees greater room for Contineum’s PIPE-791 to differentiate
The FlyJones sees greater room for Contineum’s PIPE-791 to differentiate
9d ago
BMY
CTNM
Analyst Maintains Buy Rating on Contineum (CTNM) with Unchanged $23 Price Target, Citing Positive Readthrough from Bristol Myers Squibb’s ALOFT-IPF Trial
PremiumRatings
Analyst Maintains Buy Rating on Contineum (CTNM) with Unchanged $23 Price Target, Citing Positive Readthrough from Bristol Myers Squibb’s ALOFT-IPF Trial
10d ago
CTNM
Contineum Therapeutics Inc trading resumes
PremiumThe Fly
Contineum Therapeutics Inc trading resumes
10d ago
CTNM
Contineum Therapeutics Inc trading halted, volatility trading pause
PremiumThe Fly
Contineum Therapeutics Inc trading halted, volatility trading pause
10d ago
CTNM
Contineum price target lowered to $17 from $18 at Morgan Stanley
PremiumThe Fly
Contineum price target lowered to $17 from $18 at Morgan Stanley
12d ago
CTNM
Contineum participates in a conference call with William Blair
PremiumThe FlyContineum participates in a conference call with William Blair
15d ago
CTNM
Contineum resumed at Early-Stage Biotech at Goldman Sachs
Premium
The Fly
Contineum resumed at Early-Stage Biotech at Goldman Sachs
16d ago
CTNM
Contineum price target lowered to $24 from $26 at Jones
Premium
The Fly
Contineum price target lowered to $24 from $26 at Jones
24d ago
CTNM
Contineum price target lowered to $19 from $20 at Baird
PremiumThe Fly
Contineum price target lowered to $19 from $20 at Baird
24d ago
CTNM
Closing Bell Movers: Dave & Busters down 12% after Q2
PremiumThe Fly
Closing Bell Movers: Dave & Busters down 12% after Q2
25d ago
BOOT
CTNM
Analyst Maintains Buy on Contineum, Trims Price Target to $23 Following PIPE-307 Setback While PIPE-791 IPF Program Remains Core Value Driver
PremiumRatings
Analyst Maintains Buy on Contineum, Trims Price Target to $23 Following PIPE-307 Setback While PIPE-791 IPF Program Remains Core Value Driver
25d ago
CTNM
Analyst Reaffirms Buy on Contineum, Highlighting PIPE-791 IPF Upside Despite Muscarinic MDD Trial Setback
PremiumRatings
Analyst Reaffirms Buy on Contineum, Highlighting PIPE-791 IPF Upside Despite Muscarinic MDD Trial Setback
25d ago
CTNM
Contineum Therapeutics Reports Phase 2 MOONLIGHT-1 Results
PremiumCompany AnnouncementsContineum Therapeutics Reports Phase 2 MOONLIGHT-1 Results
25d ago
8K
CTNM
Contineum says MOONLIGHT-1 trial did not achieve its primary endpoint
Premium
The Fly
Contineum says MOONLIGHT-1 trial did not achieve its primary endpoint
25d ago
JNJ
CTNM
Contineum down 11% atter MOONLIGHT-1 trial did not achieve endpoint
Premium
The Fly
Contineum down 11% atter MOONLIGHT-1 trial did not achieve endpoint
25d ago
CTNM
Contineum Therapeutics: Buy Rating Reiterated with PIPE-791 Upside Potential and Unchanged $26 Price Target
PremiumRatings
Contineum Therapeutics: Buy Rating Reiterated with PIPE-791 Upside Potential and Unchanged $26 Price Target
1M ago
CTNM
Buy Rating Reaffirmed on Contineum Therapeutics with Unchanged $26 Price Target, Backed by Advancing IPF and MDD Pipelines
PremiumRatings
Buy Rating Reaffirmed on Contineum Therapeutics with Unchanged $26 Price Target, Backed by Advancing IPF and MDD Pipelines
2M ago
CTNM
Contineum initiated with an Outperform at LifeSci Capital
PremiumThe Fly
Contineum initiated with an Outperform at LifeSci Capital
2M ago
CTNM
Contineum reports Q2 EPS (40c), consensus (45c)
PremiumThe Fly
Contineum reports Q2 EPS (40c), consensus (45c)
2M ago
CTNM
Analyst Initiates Buy on Contineum, Citing PIPE-791’s Differentiated IPF Profile and Favorable Risk-Reward Ahead of Key 2026 Readthrough
PremiumRatingsAnalyst Initiates Buy on Contineum, Citing PIPE-791’s Differentiated IPF Profile and Favorable Risk-Reward Ahead of Key 2026 Readthrough
2M ago
CTNM
Contineum Therapeutics Updates Strategy, Highlights PIPE-791 Leadership
Premium
Company Announcements
Contineum Therapeutics Updates Strategy, Highlights PIPE-791 Leadership
3M ago
8K
CTNM
Contineum publishes manuscript on PIPE-791 in Journal of Medicinal Chemistry
Premium
The Fly
Contineum publishes manuscript on PIPE-791 in Journal of Medicinal Chemistry
3M ago
CTNM

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >